Study Looking at Use of PF-07081532 in Adults with Type 2 Diabetes
Study Looking at Use of PF-07081532 in Adults with Type 2 Diabetes. Phase 1, Randomized, Double-Blind, Sponsor- Open, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus.
Category & Conditions: Diabetes and Metabolic Disorders
Medicine: PF-07081532
ClinicalTrials.gov Identifier (NCT): NCT05158244
Protocol ID: C3991003
PrintDownloadOpen Plain Language Summary Result: Click here